Fidelity Investments’s Biolase, Inc. BIOL Stock Holding History

Fidelity Investments’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5	Closed	-$1	–	5704
2024 Q1	$1	Buy	+5	New	+$2	﹤0.01%	5336
2023 Q3	–	Hold	0	–	-$2	–	5574
2023 Q2	–	Hold	0	–	–	–	5346
2023 Q1	–	Hold	0	–	–	–	5589
2022 Q4	–	Hold	0	–	–	–	5630
2022 Q3	–	Hold	0	–	–	–	5509
2022 Q1	–	Hold	0	–	–	–	5605
2021 Q4	–	Sell	-3	Closed	-$3.78K	–	5059
2021 Q3	$5K	Buy	+3	New	+$4.9K	﹤0.01%	3817
2021 Q2	–	Hold	0	–	–	–	5019
2021 Q1	–	Hold	0	–	–	–	4641
2020 Q1	–	Hold	0	–	–	–	4356
2019 Q4	–	Hold	0	–	–	–	4351

Other funds holding BIOL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity Investments's BIOL Position: Q2 2024 in Review

Fidelity Investments sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 5 shares — an estimated $1 sold.

Fidelity Investments first reported a position in BIOL in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q3 2021. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.

Fidelity Investments reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
Fidelity Investments sold 5 Biolase, Inc. shares in Q2 2024, an estimated $1.
Fidelity Investments first reported a position in Biolase, Inc. in Q3 2021 and held it in 2 quarters.
Fidelity Investments's Biolase, Inc. position peaked at $5K in Q3 2021.
2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.